They make up a subset of the entire tumor ranging from 10%-60% and can be enriched through flow cytometry sorting for cells with CD44+/CD24−/ESA+/CD49f+ surface marker phenotype and also through non-adherent mammosphere culture conditions [22-25]. Here, CD44 is linked to neoplasm.